Bone Marrow Diseases
10
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (10)
Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
Cytokine Gene Polymorphisms in Bone Marrow Failure
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.